Colin A. Leach

1.3k total citations
32 papers, 1.1k citations indexed

About

Colin A. Leach is a scholar working on Molecular Biology, Genetics and Organic Chemistry. According to data from OpenAlex, Colin A. Leach has authored 32 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 6 papers in Genetics and 5 papers in Organic Chemistry. Recurrent topics in Colin A. Leach's work include ATP Synthase and ATPases Research (9 papers), Ion Transport and Channel Regulation (8 papers) and Protein Kinase Regulation and GTPase Signaling (6 papers). Colin A. Leach is often cited by papers focused on ATP Synthase and ATPases Research (9 papers), Ion Transport and Channel Regulation (8 papers) and Protein Kinase Regulation and GTPase Signaling (6 papers). Colin A. Leach collaborates with scholars based in United Kingdom, United States and Switzerland. Colin A. Leach's co-authors include Robert J. Ife, Colin H. Macphee, David G. Tew, Deirdre M. B. Hickey, Kevin J. Milliner, Helen Boyd, David J. Keeling, Kitty Moores, Colin J. Theobald and David S. Leake and has published in prestigious journals such as Journal of Biological Chemistry, Biochemistry and Biochemical Journal.

In The Last Decade

Colin A. Leach

32 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Colin A. Leach United Kingdom	18	417	414	217	211	147	32	1.1k
Kevin J. Milliner United Kingdom	11	449 1.1×	303 0.7×	263 1.2×	50 0.2×	196 1.3×	13	892
Wendelin Frick Germany	20	223 0.5×	527 1.3×	65 0.3×	212 1.0×	81 0.6×	32	932
Saralyn Lindsey United States	19	630 1.5×	624 1.5×	236 1.1×	119 0.6×	246 1.7×	22	2.0k
Elaine Quinet United States	27	1.3k 3.2×	894 2.2×	427 2.0×	179 0.8×	198 1.3×	37	2.2k
G. Bittolo‐Bon Italy	13	786 1.9×	291 0.7×	220 1.0×	90 0.4×	151 1.0×	20	1.5k
J Seager United States	11	677 1.6×	479 1.2×	351 1.6×	71 0.3×	213 1.4×	14	1.7k
Charlotte Burton United States	16	501 1.2×	519 1.3×	158 0.7×	30 0.1×	193 1.3×	18	1.3k
Ella Born United States	22	660 1.6×	702 1.7×	132 0.6×	55 0.3×	73 0.5×	36	1.2k
Donna Yu United States	16	525 1.3×	546 1.3×	98 0.5×	31 0.1×	575 3.9×	18	1.6k
T Nishida Japan	16	436 1.0×	425 1.0×	117 0.5×	23 0.1×	57 0.4×	35	957

Countries citing papers authored by Colin A. Leach

Since Specialization

Citations

This map shows the geographic impact of Colin A. Leach's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Colin A. Leach with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Colin A. Leach more than expected).

Fields of papers citing papers by Colin A. Leach

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Colin A. Leach. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Colin A. Leach. The network helps show where Colin A. Leach may publish in the future.

Co-authorship network of co-authors of Colin A. Leach

This figure shows the co-authorship network connecting the top 25 collaborators of Colin A. Leach. A scholar is included among the top collaborators of Colin A. Leach based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Colin A. Leach. Colin A. Leach is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chambers, Janice E., Edward C. Meek, Howard W. Chambers, et al.. (2015). Novel substituted phenoxyalkyl pyridinium oximes enhance survival and attenuate seizure-like behavior of rats receiving lethal levels of nerve agent surrogates. Toxicology. 339. 51–57. 24 indexed citations

Leach, Colin A., Michael W. Thomas, Geoffrey C. Waldbieser, et al.. (2013). Histological and computed tomographic evaluation of a parasitic conjoined twin in hybrid catfish (Ictalurus punctatus [Rafinesque] X Ictalurus furcatus [Lesueur]). Journal of Fish Diseases. 37(6). 521–526. 3 indexed citations

Aiyar, N, et al.. (2010). GSK1562590, a slowly dissociating urotensin‐II receptor antagonist, exhibits prolonged pharmacodynamic activity ex vivo. British Journal of Pharmacology. 161(1). 207–228. 22 indexed citations

Bloomer, Jackie C., Murray J. B. Brown, Hung‐Yuan Cheng, et al.. (2003). The identification of clinical candidate SB-480848: a potent inhibitor of lipoprotein-associated phospholipase A2. Bioorganic & Medicinal Chemistry Letters. 13(6). 1067–1070. 100 indexed citations

Boyd, Helen, Deirdre M. B. Hickey, Robert J. Ife, et al.. (2002). Potent, orally active inhibitors of lipoprotein-associated phospholipase A2: 1-(biphenylmethylamidoalkyl)-pyrimidones. Bioorganic & Medicinal Chemistry Letters. 12(1). 51–55. 25 indexed citations

Boyd, Helen, Beverley Hammond, Robert J. Ife, et al.. (2001). The identification of a potent, water soluble inhibitor of lipoprotein-associated phospholipase A2. Bioorganic & Medicinal Chemistry Letters. 11(5). 701–704. 8 indexed citations

Bloomer, Jackie C., Helen Boyd, Robert J. Ife, et al.. (2001). 1-(Arylpiperazinylamidoalkyl)-pyrimidones: orally active inhibitors of lipoprotein-associated phospholipase A 2. Bioorganic & Medicinal Chemistry Letters. 11(14). 1925–1929. 13 indexed citations

Boyd, Helen, Deirdre M. B. Hickey, Robert J. Ife, et al.. (2000). N-1 substituted pyrimidin-4-ones: novel, orally active inhibitors of lipoprotein-associated phospholipase A2. Bioorganic & Medicinal Chemistry Letters. 10(22). 2557–2561. 24 indexed citations

Boyd, Helen, Robert J. Ife, Colin A. Leach, et al.. (2000). 2-(Alkylthio)pyrimidin-4-ones as novel, reversible inhibitors of lipoprotein-associated phospholipase A2. Bioorganic & Medicinal Chemistry Letters. 10(4). 395–398. 17 indexed citations

10.

Tew, David G., Helen Boyd, Stephen Ashman, Colin J. Theobald, & Colin A. Leach. (1998). Mechanism of Inhibition of LDL Phospholipase A₂ by Monocyclic-β-lactams. Burst Kinetics and the Effect of Stereochemistry. Biochemistry. 37(28). 10087–10093. 37 indexed citations

11.

Pope, Andrew J., Mark K. Boehm, Colin A. Leach, et al.. (1995). Properties of the reversible, K+-competitive inhibitor of the gastric (H+/K+)-ATPase, SK&F 97574. I. In vitro activity. Biochemical Pharmacology. 50(10). 1543–1549. 15 indexed citations

12.

Parsons, Michael E., et al.. (1995). properties of the reversible, K+-competitive inhibitor of the gastric H+/K+)-ATPase, SK&F 97574. II. Pharmacological properties. Biochemical Pharmacology. 50(10). 1551–1556. 7 indexed citations

13.

Leach, Colin A., Thomas H. Brown, Robert J. Ife, et al.. (1995). Reversible Inhibitors of the Gastric (H+/K+)-ATPase. 4. Identification of an Inhibitor with an Intermediate Duration of Action. Journal of Medicinal Chemistry. 38(14). 2748–2762. 22 indexed citations

14.

Ife, Robert J., Thomas H. Brown, Peter Blurton, et al.. (1995). Reversible Inhibitors of the Gastric (H+/K+)-ATPase. 5. Substituted 2,4-Diaminoquinazolines and Thienopyrimidines. Journal of Medicinal Chemistry. 38(14). 2763–2773. 38 indexed citations

15.

Leach, Colin A., Thomas H. Brown, David J. Keeling, et al.. (1992). Reversible inhibitors of the gastric (H+/K+)-ATPase. 2. 1-Arylpyrrolo[3,2-c]quinolines: effect of the 4-substituent. Journal of Medicinal Chemistry. 35(10). 1845–1852. 49 indexed citations

16.

Ife, Robert J., Thomas H. Brown, David J. Keeling, et al.. (1992). Reversible inhibitors of the gastric (H+/K+)-ATPase. 3. 3-Substituted-4-(phenylamino)quinolines. Journal of Medicinal Chemistry. 35(18). 3413–3422. 40 indexed citations

17.

Keeling, David J., et al.. (1991). SK&F 96067 is a reversible, lumenally acting inhibitor of the gastric (H+ + K+)-ATPase. Biochemical Pharmacology. 42(1). 123–130. 45 indexed citations

18.

Chandler, Michael J., C ZEISS, Colin A. Leach, et al.. (1987). Levels and specificity of antibody in bronchoalveolar lavage (BAL) and serum in an animal model of trimellitic anhydride-induced lung injury. Journal of Allergy and Clinical Immunology. 80(2). 223–229. 9 indexed citations

19.

Leach, Colin A., et al.. (1983). Nucleosides and Nucleotides. Part 21. Synthesis of a Tridecanucleoside Dodecaphosphate Incorporating the Unnatural Base 2 (1 H)‐Pyridone. Helvetica Chimica Acta. 66(2). 639–651. 9 indexed citations

20.

Waldmeier, Felix, et al.. (1982). Nucleosides and Nucleotides. Part 19. On Detritylation with Zinc Bromide in Oligonucleotide Synthesis. Helvetica Chimica Acta. 65(8). 2472–2475. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact